Does ROSUVASTATIN Cause Pleural effusion? 207 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 207 reports of Pleural effusion have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.6% of all adverse event reports for ROSUVASTATIN.
207
Reports of Pleural effusion with ROSUVASTATIN
0.6%
of all ROSUVASTATIN reports
22
Deaths
181
Hospitalizations
How Dangerous Is Pleural effusion From ROSUVASTATIN?
Of the 207 reports, 22 (10.6%) resulted in death, 181 (87.4%) required hospitalization, and 16 (7.7%) were considered life-threatening.
Is Pleural effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 207 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Pleural effusion?
DASATINIB (2,424)
METHOTREXATE (1,310)
CYCLOPHOSPHAMIDE (1,239)
IBRUTINIB (1,205)
RITUXIMAB (1,168)
PREDNISONE (1,144)
NIVOLUMAB (1,061)
ADALIMUMAB (1,036)
DEXAMETHASONE (879)
PACLITAXEL (862)
Which ROSUVASTATIN Alternatives Have Lower Pleural effusion Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN